再组合的人类腺病毒p53与肝癌的跨导管动脉化学栓塞相结合:一个元分析

相关实验视频

Updated: Jul 7, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

444

Yaru Guo1, Yuanyuan Chen1, Yingnan Zhang1

  • 1Department of Radiation, Xuzhou first People's Hospital, Jiangsu, China.

PloS one
|December 21, 2023
PubMed
概括

再组合的人类腺病毒-p53 (rAd-p53) 结合过导管动脉化学栓塞 (TACE) 显著改善肝癌治疗结果. 这种组合疗法增强了瘤反应,存活率和生活质量,同时改善了免疫功能,并具有可控的副作用.

更多相关视频

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.5K
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

13.3K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K